Stay updated on Atezolizumab with BCG in NMIBC Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab with BCG in NMIBC Clinical Trial page.
Latest updates to the Atezolizumab with BCG in NMIBC Clinical Trial page
- Check3 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. The update does not modify any study details, eligibility criteria, endpoints, or enrollment.SummaryDifference0.0%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedAdded a consolidated Locations section listing study sites in CA, IL, MD, NY, NC, OH, OK, and OR. Per-state location blocks were removed, and the page revision updated from v3.3.2 to v3.3.3.SummaryDifference0.9%
- Check53 days agoChange DetectedAdded a note indicating that publications are automatically filled from PubMed and may not be about the study; updated the page revision to v3.3.2.SummaryDifference0.1%
- Check60 days agoChange DetectedThe site-wide operating status notice has been removed, which is administrative and does not affect core trial information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check74 days agoChange DetectedNo significant changes detected between the old and new page versions; the Study Details and location information appear unchanged.SummaryDifference0.4%
- Check103 days agoChange DetectedMajor update: operating-status notice and new version v3.2.0; old v3.1.0 reference removed.SummaryDifference2%
Stay in the know with updates to Atezolizumab with BCG in NMIBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab with BCG in NMIBC Clinical Trial page.